FK409, a new nitric-oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty

Atherosclerosis

Volumn 117, Issue 1, 1995, Pages 97-106

  Seki, Jiro ^a   Nishio, Mie ^a   Kato, Yasuko ^a   Motoyama, Yukio ^a   Yoshida, Keizo ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Angioplasty; Anti proliferative effect; Cyclic GMP; Intimal thickening; Nitric oxide donor; Smooth muscle cells

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; CAPTOPRIL; CYCLIC GMP; ISOSORBIDE DINITRATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

ANGIOPLASTY, BALLOON; ANIMAL; BROMODEOXYURIDINE; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL DIVISION; CELLS, CULTURED; CYCLIC GMP; DISEASE MODELS, ANIMAL; ISOSORBIDE DINITRATE; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRO COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; TUNICA INTIMA; VASODILATOR AGENTS;

EID: 0029133926     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05563-C     Document Type: Article

References (45)

1. Prevention of restenosis after percutaneous transluminal coronary angioplasty; the search for “magic bullet”
2. Clinical trials of restenosis after coronary angioplasty
3. Restenosis following coronary angioplasty: role of smooth muscle cell proliferation
4. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies
5. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
6. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
7. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium
8. Comparative pharmacology of endothelium-derived relaxing factor nitric oxide and prostacyclin in platelets
9. Nitric oxide: an endogenous modulator of leukocyte adhesion
10. Nitric oxide: physiology, pathophysiology and pharmacology
11. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
12. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells
13. Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators
14. L-arginine inhibits neointimal formation following balloon injury
15. L-arginine inhibits balloon catheter-induced intimal hyperplasia
16. NG-nitro-L-arginine methyl ester does not affect balloon-induced intimal hyperplasia in rats
17. FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus. I. Taxonomy, fermentation, isolation, and physicochemical and biological characteristics
18. Characterization of the vasorelaxing action of (3E)-4-ethyl-2-hydroximino-5-nitro-3-hexamide FK409, a new vasodilator isolated from microbial sources, in isolated rabbit arteries
19. Comparison of the effects of the novel vasodilator FK409 with those of nitroglycerin in isolated coronary artery of the dog
20. FK409-induced vasorelaxation; the role of nitric oxide (NO)
21. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409
22. Mechanisms of stenosis after arterial injury
23. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery
24. The smooth muscle cell. II. Growth of smooth muscle cell in culture and formation of elastic fibres
25. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury
26. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury
27. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition
28. Kinetics of cellular proliferation after arterial injury: I. Smooth muscle growth in the absence of endothelium
29. Vasorelaxant mechanism of the new vasodilator, FK409
30. Hemodynamic mechanisms of the antianginal action of a novel vasodilator FK409 in dynamic exercise-induced angina
31. The smooth muscle cell in culture
32. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor
33. Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor
34. In vivo and in vitro inhibition of JE gene expression by glucocorticoids
35. Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines
36. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo
37. Anti-platelet activities of FK409, a new spontaneous NO releaser
38. Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazol (KC-6144), an anti-aggregating compound, on experimental thrombosis in rats
39. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty
40. Inhibition of platelet activity by s-nitrosoglutathione during coronary angioplasty
41. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase
42. Inhibition of platelet function by organic nitrate vasodilators
43. The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders
44. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates
45. Mechanisms of nitrate tolerance: a review